The global anti-neoplastic therapy market size was valued at USD 134 billion in 2022 and is poised to grow at a CAGR of 7.8% during the forecast period 2022-2028. It also includes market size and projection estimations for each of the five major regions from 2022 to 2028. The primary factors that drive the market are the increasing demand for personalized medicines, the growing prevalence of cancer, an increase in research and development activities in biotechnology and pharmaceutical companies along with technological progression in anti-neoplastic therapy.

View the detailed report description here -

The global anti-neoplastic therapy market segmentation:
By Agent Type: Alkylating and Alkylating-Like Agents, Antimetabolites, Antitumor Antibiotics, Plant Alkaloids, Hormonal Agents, and Miscellaneous Agents
2) Product Type: Chemotherapeutic Agents, Immunotherapeutic Agents, and Personalized Medicine
3) Cancer Type: Bladder Cancer, Prostate Cancer, Blood Cancer, Melanoma, Breast Cancer, Throat Cancer, Kidney Cancer, Uterine Cancer, Lungs Cancer, and Other
4) End Users: Hospitals, Clinics, Research Institutes, Cancer Rehabilitation Centers, and Others.

Based on product type, the chemotherapeutic agent holds the highest market share. The major factor for the rise of this segment is that the drugs are easily available. It is expected that the number of cancer patients can increase in manifolds in the upcoming years. Apart from this, effective treatment of chemotherapeutics and the ability of this technique to stop the spreading of cancerous cells far away from the initial tumor cell can drive market growth further. Technologically advanced products and government initiatives to promote awareness about chemotherapeutics can also boost market growth.

Request sample report at

Asia Pacific region is expected to grow significantly in the global anti-neoplastic therapy market over the forecast period. The Asia Pacific region is expanding as a result of an increase in research and development activities in academic institutes and laboratories, increasing cancer cases, and awareness among the people for personalized medications. North America leads the global market due to entrenched research infrastructure, increasing funding from public and private sectors, and rising collaborations among global key players have contributed to increasing the sales of anti-neoplastic therapy in this region. Apart from this, the major factor that drives the market in this region is the high prevalence of chronic diseases such as cancer. According to NIH, 1,806,509 people were diagnosed with cancer in the United States and 606,520 cases of death were reported.

Request Methodology        

The global anti-neoplastic therapy market key players are AbbVie Inc., Pfizer Inc., Boehringer Ingelheim, Bayer AG, Eli Lilly and Company, Amgen Inc., Johnson and Johnson, Merck and Co., Teva Pharmaceutical Industries Ltd, and AstraZeneca Inc.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: | D U N S® Number: 852781747